Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura L Laidler

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Reproductive Medicine|May 29, 2010
Inherited human chorionic gonadotropinLaurence A Cole, Laura L Laidler
Clinical Biochemistry|May 25, 2010
USA hCG reference service, 10-year reportLaurence A Cole, Laura L Laidler, Carolyn Y Muller
Molecular Cancer Therapeutics|December 24, 2005
Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumorsLina Albitar, Laura L Laidler, Rony Abdallah, et al.
Molecular Cancer Therapeutics|January 20, 2005
A therapeutic model for advanced endometrial cancer: systemic progestin in combination with local adenoviral-mediated progesterone receptor expressionDonghai Dai, Lina Albitar, Tan Nguyen, et al.
Gynecologic Oncology|November 14, 2012
Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53Xiangbing Meng, Laura L Laidler, Elizabeth A Kosmacek, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Reproductive Medicine|May 29, 2010
Inherited human chorionic gonadotropinLaurence A Cole, Laura L Laidler
Clinical Biochemistry|May 25, 2010
USA hCG reference service, 10-year reportLaurence A Cole, Laura L Laidler, Carolyn Y Muller
Molecular Cancer Therapeutics|December 24, 2005
Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumorsLina Albitar, Laura L Laidler, Rony Abdallah, et al.
Molecular Cancer Therapeutics|January 20, 2005
A therapeutic model for advanced endometrial cancer: systemic progestin in combination with local adenoviral-mediated progesterone receptor expressionDonghai Dai, Lina Albitar, Tan Nguyen, et al.
Gynecologic Oncology|November 14, 2012
Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53Xiangbing Meng, Laura L Laidler, Elizabeth A Kosmacek, et al.
Pageof 1